Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Gusto Global LLC is currently processing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners and 2 distinct art units, suggesting that the company's technology is being evaluated by two different specialized groups at the USPTO. This distribution means that the company cannot rely on a single set of examiner behaviors or art unit norms.
The busiest examiner, DICKENS, AMELIA NICOLE, is responsible for 1 busiest examiner pending action. This accounts for one of the 2 pending office actions currently active. With 2 distinct examiners and 2 distinct art units, the company must manage two separate prosecution paths within the Biotechnology & Pharmaceuticals area. This distribution requires the company to be prepared for different examiner styles and art unit standards for their 2 pending office actions, as they are being processed by different individuals in different specialized units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DICKENS, AMELIA NICOLE | 1 | 47.2% | +21.6% |
| AFREMOVA, VERA | 1 | 50.5% | +29.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18032745 | MICROBIAL-BASED COMPOSITIONS FOR SYSTEMIC INFLAMMATION CONTROL | AFREMOVA, VERA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18367513 | RATIONAL DESIGN OF MICROBIAL-BASED BIOTHERAPEUTICS | DICKENS, AMELIA NICOLE | — |
| 18032745 | MICROBIAL-BASED COMPOSITIONS FOR SYSTEMIC INFLAMMATION CONTROL | AFREMOVA, VERA | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18367513 | RATIONAL DESIGN OF MICROBIAL-BASED BIOTHERAPEUTICS | DICKENS, AMELIA NICOLE | 1645 | §103 | Final Rejection | — | Pending | Sep 13, 2023 |
| 18032745 | MICROBIAL-BASED COMPOSITIONS FOR SYSTEMIC INFLAMMATION CONTROL | AFREMOVA, VERA | 1653 | §101 | Final Rejection | — | Pending | Apr 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGusto Global LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Amelia Nicole Dickens has the most, with 1 of Gusto Global LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
